Objective: This study was designed to compare with placebo the dose-response effect of cyclical doses of the C21 progestogen, medroxyprogesterone acetate (MPA) on blood pressure (BP) when administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results